1996
DOI: 10.1016/0006-2952(96)00063-9
|View full text |Cite
|
Sign up to set email alerts
|

Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
48
1

Year Published

2002
2002
2015
2015

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 73 publications
(54 citation statements)
references
References 39 publications
5
48
1
Order By: Relevance
“…To test this hypothesis, COS-1 cells were transfected with either pcDNA3/␤mAhR or pcDNA3/␤mAhR plus pCI/XAP2 at two different levels, followed by treatment with various concentrations of iodoflavone. Iodoflavone was chosen because it has intermediate affinity for the AhR (25). AhR transcriptional activity was assessed using a DRE-driven luciferase reporter.…”
Section: Xap2 Represses Mahr Transactivation Potential At Lowmentioning
confidence: 99%
“…To test this hypothesis, COS-1 cells were transfected with either pcDNA3/␤mAhR or pcDNA3/␤mAhR plus pCI/XAP2 at two different levels, followed by treatment with various concentrations of iodoflavone. Iodoflavone was chosen because it has intermediate affinity for the AhR (25). AhR transcriptional activity was assessed using a DRE-driven luciferase reporter.…”
Section: Xap2 Represses Mahr Transactivation Potential At Lowmentioning
confidence: 99%
“…CYP1A1 and CYP1A2 protein expression and catalytic activities are induced in the liver and other tissues by some of those same substrates (Eaton et al, 1995). In particular, flavonoids have been reported to bind to the Ah receptor involved in CYP1A isoform induction, leading to increased synthesis of CYP1A1 and CYP1A2 (Huang et al, 1981;Lu et al, 1995Lu et al, , 1996. In addition, P450s are involved in enzymatic activation of a number of antitumor agents in the liver (e.g., cyclophosphamide, dacarbazine, and trans-retinoic acid), lending plausibility to the idea that a cytotoxic flavonoid might induce the P450s that metabolize it to active species.…”
Section: Af (mentioning
confidence: 99%
“…The cell context-and gene-specific AhR agonist and antagonist activities of the tryptophan metabolites are not unique and have been observed for other AhR ligands including 6-methyl-1,3,8-trichlorobenzofuran, flavonoids, and pharmaceuticals (Astroff et al, 1988;Lu et al, 1996;McDougal et al, 2001;Zhou and Gasiewicz, 2003;Jin et al, 2012;Safe et al, 2012). We also observed that the AhR antagonist CH inhibited Cyp1a1 induction by TCDD and the tryptophan metabolites, indicating that CH inhibited induction of Cyp1a1 by a diverse spectrum of AhR ligands, as previously reported elsewhere (Choi et al, 2012).…”
Section: Downloaded Frommentioning
confidence: 99%